By John Shultz Randy Rasmussen, CEO of BioFire Diagnostics, delivered the keynote speech at the 2018 bioMérieux “Night at the Museum” event held in Salt Lake City, Utah on July 9th, 2018. In his talk, Randy relates the challenges he has faced in his own career in the fight against infectious disease, while reflecting on …
The Necessity of Innovative Diagnostics in Controlling Antibiotic Resistance in Patients with Cystic Fibrosis
Dr. Hahn advocates for a more proactive microbiology lab to closely monitor the types of CF infections and to determine which antibiotics each infection is most susceptible. In the Children’s National study, researchers analyzed each sample in two different ways: standard lab culture and molecular testing.
“Drug-Bug Match Auto-Posting” Reduces CRE Infections by more than 10% In New York Hospital
Interview with Vincent J. LaBombardi, Ph.D. Carbapenem-resistant Enterobacteriaceae, or CRE, have been called, “nightmare bacteria,” because the multi-drug-resistant infections are so difficult to treat and can be deadly in up to 50% of cases, according to the Centers for Disease Control and Prevention (CDC). These bacteria produce an enzyme called carbapenemase that breaks down carbapenem …
Quick Facts About Sepsis
Learn about sepsis: what it is, what causes it, who is at risk, and how it’s diagnosed and treated.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...